Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigator Unit Sponsorsort descending Date
WAESO: Exercised Sheep Loading and Motion Analysis Grant $460.50 Research Training John Szivek Orthopaedic Surgery Arizona State University 07/2020
Compassionomics Grant $700.00 Research Susan McCartan COM Phoenix Academic Affairs Arnold P. Gold Foundation 03/2020
Total Shoulder Arthroplasty Multi-Center Registry Contract $603,643.00 Clinical Trial Joshua Hustedt COM Phx Orthopedics Arthrex, Incorporated 06/2020
A Phase Ib/II Study of APG-115 in Combination with Pembrolizumab in Patients with Unresectable or Metastatic Melanomas or Advanced Solid Tumors Contract $513,891.00 Clinical Trial Montaser Shaheen Cancer Center Division Ascentage Pharma 01/2020
Developing and Piloting a Scalable, Online, Interprofessional Health Equity and Social Justice Course Contract $6,000.00 Research Elizabeth Hall-Lipsy Pharmacy Practice and Science Association for Prevention Teaching and Research 02/2021
UT2 Autism Intervention Research Network for Physical Health (AIR-P) Cooperative Agreement $20,000.00 Other Sponsored Activity Wendy Parent-Johnson Family and Community Medicine Association of University Centers on Disability 03/2021
A Phase 1 Study of Safety, Pharmacokinetics and Preliminary Activity of TAS1440, as a Single Agent and in Combination with All-Trans Retinoic Acid (ATRA) in Subjects with Relapsed or Refractory (r/r) Contract $128,345.24 Clinical Trial Sharad Khurana Cancer Center Division Astex Pharmaceuticals Incorporated 06/2021
A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with... Contract $1,278,228.50 Clinical Trial Charles Hsu Radiation Oncology Astrazeneca 08/2020
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with Either Durvalumab Monotherapy or Durvalumab Plus Bevacizumab Contract $208,612.70 Clinical Trial Gregory Woodhead Cancer Center Division Astrazeneca 06/2020
A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies Contract $468,451.00 Clinical Trial Alejandro Recio Boiles Cancer Center Division Atreca, Inc. 10/2020
Mycardia Implant Viability and Biodistribution in RNU Rats Contract $18,977.00 Research - Industry (62.5% MTDC) Joshua Strom Cellular & Molecular Medicine Avery Therapeutics 09/2020
A Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of the RECELL System Combined with Meshed Autograft for Reduction of Donor Skin Harvesting Contract $229,008.88 Clinical Trial Lourdes Castanon Surgery Avita Medical Americas, LLC 01/2021
Arizona Alzheimer's Disease Core Center (ADCC) - Developing Inhibitors of TDP-43/Tau Interaction for AD Therapeutics Grant $46,050.00 Research May Khanna Pharmacology Banner Health System 02/2021
Disease Morphology Image Study Protocol: A Retrospective, Multicenter, Data collection study for information about the disease morphology and stent restenosis patterns in the Iliac and SFA arteries, w Contract $17,187.52 Clinical Trial Kresimira Milas Surgery Bard Peripheral Vascular, Inc. 05/2020
Invasive Cardiopulmonary Exercise Testing to Phenotype Post Pulmonary Embolism Dyspnea Contract $99,577.00 Clinical Trial Michael Insel Medicine Bayer Healthcare Pharmaceuticals Incorporated 11/2020
An Open-Label Study of Regorafenib in Combination with Pembrolizumab in Patients with Advanced or Metastatic Hepatocellular Carcinoma (HCC) after PD-1/PD-L1 Immune Checkpoint Inhibitors Contract $345,140.00 Clinical Trial Rachna Shroff Cancer Center Division Bayer Healthcare Pharmaceuticals Incorporated 04/2021
A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Finerenone on Morbidity and Mortality in Participants with Heart Failure (NYHA Contract $883,627.00 Clinical Trial Preethi William Sarver Heart Center Bayer Healthcare Pharmaceuticals Incorporated 05/2021
An Open-label, Phase 1, First-in-human, Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Maximum Tolerated or Administered Dose, Pharmacokinetics, Pharmacodynamics and Tumor.. Contract $2,247,249.52 Clinical Trial Ricklie Julian Cancer Center Division Bayer Pharmaceutical 04/2021
Space-based Paper Microfluidic Vertical Flow Assay for Rapid Multiplex Diagnostics (VFD) in COVID-19 Pandemic Response and Recovery Cooperative Agreement $149,958.00 Research Frederic Zenhausern COM Phx NanoBioscience & Med Baylor College of Medicine 07/2020
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer Cooperative Agreement $64,679.91 Research Denise Roe Cancer Center Division Beckman Research Institute of The City of Hope 03/2020
Immune Tolerance Network Cooperative Agreement $585,150.00 Clinical Trial Tara Carr Asthma/Airway Disease Rsch Ctr Benaroya Research Institute at Virginia Mason 05/2021
Establishing an Animal Model to Evaluate Nox4 Inhibitors for Skin Fibrosis Grant $450.00 Research Training Louise Hecker Medicine Beta Beta Beta National Biological Honor Society 05/2020
Evaluating Efficacy of NADPH Oxidase-4 Inhibitors for Pro-Fibrotic Effects in Skin Fibrosis Grant $450.00 Research Training Louise Hecker Medicine Beta Beta Beta National Biological Honor Society 05/2020
Evaluation of Novel Nox4 Inhibitor on Alveolar Epithelial Cell Proliferation Grant $450.00 Research Training Louise Hecker Medicine Beta Beta Beta National Biological Honor Society 05/2020
A Multicenter, Double-Blind, Multidose, Placebo-Controlled, Randomized, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 for Patients with Brain Contusion Contract $96,267.00 Clinical Trial Bellal Joseph Surgery Biogen Incorporated 03/2020

Pages